Kengo Kawase, MD

Disclosure information not submitted.

Presentation(s):

• MP05-03: Hypoxia-inducible prolyl hydroxylase inhibitor (Roxadustat) suppresses kidney stone formation.

  Friday, May 13, 2022
  8:45 AM – 10:00 AM